27th Annual FSHD International Research Congress Goes Virtual
The FSHD Society announced the opening
today of its 27th annual International Research Congress (IRC), which is being
conducted entirely online for the first time in the organization’s history. The
conference is widely seen as the premier global platform for the discussion and
dissemination of state-of-the-art research on facioscapulohumeral Oklahoma
News muscular dystrophy (FSHD). A record 210 researchers, clinicians,
industry representatives and patient advocates are attending.
“Due to the global COVID-19
crisis, we have deployed a robust virtual conference platform for the 2020 IRC
which has opened the opportunity to Oklahoma Business News participate
for many researchers who previously could not afford the time or cost of
travel,” noted Jamshid Arjomand, PhD, chief science officer of the Society.
Researchers who have convened
at this gathering since 1994 have helped drive fundamental discoveries, arriving
at a broad consensus on a central hypothesis of the genetic basis of FSHD,
development of cellular and animal models, identification of multiple
therapeutic targets, and the validation of clinical outcome measures. These
fundamental discoveries and collaborations have advanced Oklahoma
Political News field, prompting observational and clinical studies –
including an ongoing Phase 2b clinical trial for the first disease-modifying
therapy for FSHD as well as a large natural history study called ReSOLVE. These
studies, as well as other clinical research, have responded to the challenges
of collecting data while keeping volunteers Oklahoma Press Release safe during the COVID-19 pandemic.
The program committee made
special efforts to attract clinical and industry researchers, as advancement of
drug development brings greater urgency to improving the understanding of the
clinical features of FSHD, genotype-phenotype correlations, natural history,
and evaluation of disease progression. As a result, the number of attendees and
scientific presentations Oklahoma Sports News has nearly
doubled over the past two years.
A growing number of companies
have elected to sponsor the FSHD International Research Congress as they enter
the field of FSHD diagnostics Oklahoma Cryptocurrency News and
therapy development. This year’s foundation and industry supporters include:
Association Français Contre les Myopathies, Avidity, Bionano, Dyne
Therapeutics, Fulcrum Therapeutics, Genomic Vision, miRecule, Muscular
Dystrophy Association, National Institutes of Health, PerkinElmer Genomics, and
the University of Nevada Reno.
“With the recent advances in
FSHD studies now including large sets of data, greater availability of
biomaterials from multiple large research initiatives, and the rapid approach
of more clinical trials,” the program committee stated. “The FSHD
International Oklahoma Local News Research Congress serves a
more important role than ever: to ensure dissemination of the latest ideas and
discussion of the field’s needs and priorities, combined with collaboration and
coordination, to speed up progress toward delivering effective treatments to
our patients and families.”
About the FSHD Society
The FSHD Society is the world’s
largest research-focused patient organization for facioscapulohumeral muscular
dystrophy (FSHD), one of the most prevalent forms of muscular dystrophy. The
Society has catalyzed major advancements and is accelerating the development of
treatments and a cure to end the Oklahoma Stock Market the
pain, disability, and suffering endured by one million people worldwide who
live with FSHD. The FSHD Society has transformed the landscape for FSHD
research and is committed to making sure that no one faces this disease
alone.
Source:-
https://www.prweb.com/releases/27th_annual_fshd_international_research_congress_goes_virtual/prweb17200514.htm
No comments